Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

TLR3-independent activation of mast cells by cytomegalovirus contributes to control of pulmonary infection

Cellular & Molecular Immunology volume 14, pages 479–481 (2017)Cite this article

Interstitial pneumonia is a life-threatening clinical manifestation of human cytomegalovirus (hCMV) infection. In particular, it can be deadly in patients with hematopoietic malignancies who undergo hematopoietic cell transplantation (HCT) in whom a ‘window of risk’, which is defined by transient immunodeficiency, occurs between hematoablative therapeutic treatment and immunological reconstitution. As few clinical studies have addressed the underlying mechanisms for this phenomenon, a mouse model of HCT and murine cytomegalovirus (mCMV) infection has been established and has revealed a key role for antiviral CD8+ T cells in controlling pulmonary infections. Using this mouse model, recent studies have provided evidence for the role of mast cells (MC) in more efficiently recruiting antiviral CD8+ T cells to CMV-infected lungs in a process that involves the release of CCL5, a chemokine. MC were found to be direct cellular targets of murine CMV infection and could be activated and degranulated by two mechanisms: the rapid degranulation requiring TLR3/TRIF signaling in non-MC cells and a delayed TLR3/TRIF-independent mechanism. Here, we provide evidence showing that TLR3/TRIF-independent MC activation by CMV is the dominant mechanism in controlling pulmonary infection.

As human cytomegalovirus (hCMV) can establish a life-long latent infection, which under immunocompromised conditions carries a risk of reactivation to recurrent productive infection with multiple organ manifestations, it represents a major risk to patients at transplantation centers worldwide who are solid organ transplantation (SOT) or hematopoietic cell transplantation (HCT) recipients. In particular, the lungs of HCT recipients are susceptible to CMV disease and have a high risk of developing lethal interstitial pneumonia if left untreated. As CMVs are strictly host species-specific, hCMV cannot be studied in animal models. The mCMV model has reproduced most aspects of hCMV pathogenesis that are observed in patients. Specifically, the lungs represent a major site of CMV latency, reactivation, and pathogenesis in both hCMV-infected humans and mCMV-infected mice.1, 2, 3, 4 In general, the animal model has been instrumental in mimicking hCMV disease to address principles of CMV–host interactions5 and to test new strategies for therapeutic intervention, such as cytoimmunotherapy,6 by focused experimental studies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

References

  1. Reddehase MJ, Weiland F, Münch K, Jonjic S, Lüske A, Koszinowski UH . Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 1985; 55: 264–273.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Balthesen M, Messerle M, Reddehase MJ . Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 1993; 67: 5360–5366.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Kurz SK, Rapp M, Steffens HP, Grzimek NK, Schmalz S, Reddehase MJ . Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J Virol 1999; 73: 482–494.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Podlech J, Holtappels R, Pahl-Seibert MF, Steffens HP, Reddehase MJ . Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: persistence of protective pulmonary CD8-T-cell infiltrates after clearance of acute infection. J Virol 2000; 74: 7496–7507.

    Article  CAS  Google Scholar 

  5. Reddehase MJ . Mutual interference between cytomegalovirus and reconstitution of protective immunity after hematopoietic cell transplantation. Front Immunol 2016; 7: 294.

    Article  Google Scholar 

  6. Holtappels R, Böhm V, Podlech J, Reddehase MJ . CD8 T-cell-based immunotherapy of cytomegalovirus infection: proof of concept provided by the murine model. Med Microbiol Immunol 2008; 197: 125–134.

    Article  Google Scholar 

  7. Ebert S, Becker M, Lemmermann NA, Büttner JK, Michel A, Taube C et al. Mast cells expedite control of pulmonary murine cytomegalovirus infection by enhancing the recruitment of protective CD8 T cells to the lungs. PLoS Pathog 2014; 10: e1004100.

    Article  Google Scholar 

  8. Becker M, Lemmermann NAW, Ebert S, Baars P, Renzaho A, Podlech J et al. Mast cells as rapid innate sensors of cytomegalovirus by TLR3/TRIF signaling-dependent and -independent mechanisms. Cell Mol Immunol 2015; 12: 192–201.

    Article  CAS  Google Scholar 

  9. Yung S, Chan TM . Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells. Mediators Inflamm 2012; 2012: 484167.

    Article  Google Scholar 

  10. Podlech J, Ebert S, Becker M, Reddehase MJ, Stassen M . Lemmermann NAW. Mast cells: innate attractors recruiting protective CD8 T cells to sites of cytomegalovirus infection. Med Microbiol Immunol 2015; 204: 327–334.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Michael Stassen and Ann-Kathrin Hartmann of the Institute for Immunology for sharing their expertise in MC biology. Ethics statement: The animal research protocol was approved by the ethics committee of the Landesuntersuchungsamt Rheinland-Pfalz according to German Federal Law §8 Abs. 1 TierSchG, permission no. 23 177-07/G09-1-004.

Author information

Authors and Affiliations

  1. Institute for Virology and Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.

    Niels A W Lemmermann & Matthias J Reddehase

Authors
  1. Niels A W Lemmermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthias J Reddehase
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Niels A W Lemmermann.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lemmermann, N., Reddehase, M. TLR3-independent activation of mast cells by cytomegalovirus contributes to control of pulmonary infection. Cell Mol Immunol 14, 479–481 (2017). https://doi.org/10.1038/cmi.2017.23

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cmi.2017.23

Search

Advanced search

Quick links